Slow Weight Research Articles

Infancy weight faltering and childhood neurodevelopmental disorders: a general population birth-cohort study.

While it is known that intrauterine growth restriction is associated with later mental disorders, it is still unclear whether similar associations exists for postnatal weight faltering, also known as 'failure to thrive' in infancy. This study examined the potential connection between infancy weight faltering and mental disorders diagnosed in childhood focusing specifically on neurodevelopmental disorders. The Copenhagen Child Cohort (CCC2000) was used to explore weight gain in infancy assessed by community health nurses. Data from the Danish national registries were used to quantify ICD-10 mental disorders diagnosed between birth and 12 years of age, as well as potential child and family confounders. Of 4.476 children with sufficient weight data, 339 (7.3%) children were diagnosed with a mental disorder in childhood. Both any (weight gain < -1SD) and severe infancy weight faltering (weight gain < -2SD) were associated with psychomotor delays, while severe infancy weight faltering was also associated with intellectual impairments. Notably, no significant associations were found between weight faltering and autism spectrum disorders or attention deficit hyperactivity disorders. Weight faltering in infancy may be an early marker of neurodevelopmental delays. This possibility should be considered when assessing infants with slow weight gain, to early identification and treatment of co-occurring neurodevelopmental disorders.

A novel anti-obesity mechanism for liraglutide by improving adipose tissue leptin resistance in high-fat diet-fed obese mice.

Liraglutide has been approved for the treatment of obesity in the past few years. Both oxidative stress and leptin resistance are the critical drivers of obesity. The present study investigated the mechanism of liraglutide protection against obesity by ameliorating leptin resistance and oxidative stress. Male C57BL/6J mice were fed a high-fat diet (HFD) and subcutaneously injected with 200 μg/kg/d liraglutide for 20 weeks. Body weight, fat mass, serum levels of leptin, insulin, and superoxide dismutase (SOD) activities were measured. In addition, glucose and insulin tolerance tests were performed. The expressions of leptin, its signaling genes, and antioxidant enzymes were detected using RT-qPCR and western blot methods in liver and white adipose tissue (WAT) of mice. The results depicted that liraglutide treatment significantly slowed weight gain of body, reduced the fat mass, ameliorated glucose and lipid metabolism, and hepatic steatosis in HFD-fed obese mice. Further study demonstrated that liraglutide treatment resulted in decreased serum levels and the transcript levels of leptin as well as leptin signaling inhibitory regulators. However, it increased leptin receptor expression and the phosphorylation of signal transducer and activator of transcription 3 (p-STAT3) in WAT (p < 0.05). In addition, the antioxidant enzyme expression was elevated in both liver and WAT of liraglutide-treated mice (p < 0.05). In conclusion, liraglutide conspicuously prevented obesity and ameliorated glucose and lipid metabolism in obese mice through a novel mechanism that improves peripheral leptin resistance in WAT and enhance the antioxidant enzyme expression in both liver and WAT.

Anti-obesity effects of galacto-oligosaccharides in obese rats

Galacto-oligosaccharides (GOS) are commonly used as prebiotic with a variety of known metabolic benefits; however, whether GOS plays a protective role in obesity remains unknown. Here, we demonstrate that GOS prevented obesity in a rat model of obesity induced by a high-fat diet. Our results showed that GOS effectively slowed weight gain in diet-induced obese rats without affecting energy intake. GOS significantly suppressed the hypertrophy and hyperplasia of white adipose tissue and markedly reduced the ratio of the fat/body. Consistently, GOS significantly improved serum total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol levels, indicating the weight loss activity of GOS. Interestingly, GOS also significantly increased the expression levels of browning proteins, including uncoupling protein 1, peroxisome proliferator-activated receptor-γ, peroxisome proliferator-activated receptor-γ coactivator 1α, and PR domain 16, in both white and brown adipose tissue. Furthermore, we found that GOS markedly increased the expression levels of liver X receptor α, peroxisome proliferation-activated receptor-α, low-density lipoprotein receptor, and cholesterol 7α-hydroxylase proteins in the liver of obese rats. Taken together, we concluded that GOS inhibits obesity by accelerating the browning of white fat cells and the thermogenesis of brown fat cells and that GOS improves host lipid homeostasis by promoting cholesterol catabolism.

Manifestation of proliferative enteropathy of pigs (ileitis) in pig farms of Ukraine (diagnostic monitoring)

Proliferative enteropathy of pigs (PPE; ileitis, lawsoniosis) is one of the most common, relatively new and little-studied gastrointestinal diseases of pigs which cause significant economic damage to the pig industry worldwide. The causative agent of ileitis is Lawsonia intracellularis, a gram-negative intracellular bacterium. The incubation period lasts from two to three weeks, the infection has a high degree of infection. The pathogen is transmitted from animal to animal by oral and fecal route. In order to study the manifestations of proliferative enteropathy of pigs on farms in Ukraine, we surveyed 32 farms in 13 regions. The course of PPE was usually observed with symptoms of gastrointestinal disorders, but the disease brought significant economic losses. A characteristic symptom of the chronic course in the studied farms of Ukraine is a slow but progressive weight loss of animals and, as a result, diarrhea and loss of appetite. Clinical signs of ileitis depend on the form of the course. There are three main forms of ileitis: chronic form — intestinal adematosis, acute — hemorrhagic enteropathy and subclinical form. According to our research, the acute form is manifested by pale skin and signs of anemia, hemorrhagic diarrhea and sudden death of the animal. Pigs weighing more than 70 kg suffer the most. The pathological picture characteristic of PPE was observed already at the age of 33 days; 62.5% of the dead piglets aged 33 to 102 days were affected by Lawsonia, which was confirmed by laboratory tests. Pathological examination was observed in the dead pigs of the rearing and fattening group: duodenum — part initially covered with mucus-fibrin; ileum — thickening of the walls, on the serous membrane dark red grooves like a mosaic, dark blood, blood coagulates cylindrical forms; mucous membrane is uneven, thickened, intensely red; colon — stretched through gases, blood dark with coagulates in the lumen; rectum — the contents are thick to semi-liquid, dark red; mesenteric lymph nodes — enlarged and hyperemic. Pathohistological changes in the intestine varied. In some parts of the intestine, there were characteristic of ulcerative necrotic ileitis, and in others — for proliferative enteropathy.

Role of TLR4/MyD88 Signaling Pathway in the Occurrence and Development of Uremia-Induced Myocardial Hypertrophy and Possible Mechanism.

The morbidity and mortality of cardiovascular disease (CVD) are relatively high. Studies have shown that most patients with chronic kidney disease (CKD) die from cardiovascular complications. Clinically, the pathophysiological state in which heart disease and kidney disease are causal and influence each other is called cardiorenal syndrome (CRS). Myocardial hypertrophy is the key stage of the heart structure changing from reversible to irreversible. It is an important pathophysiological basis for heart failure. Therefore, this study intends to start with the end-stage uremic phase of CKD to construct an animal model of uremia in rats to study the relationship between uremia, TLR4/MyD88 signaling pathway, and myocardial hypertrophy. The results showed that the uremic rats showed slow weight gain and were thinner. At 12 weeks (w), the serum creatinine and urea nitrogen of the uremic rats increased, and the global hypertrophy index increased. Detecting the expression of Toll-like receptor 4 (TLR4) and myeloid differentiation factor (MyD88) in blood samples of rats, we found that the expression of TLR4 and MyD88 increased at 12 w in the uremia group; pathological observation showed that at 4 weeks of uremia model rats, renal tissue compensatory hypertrophy, renal fibrous membrane proliferation, renal parenchyma atrophy, a large number of fibrous proliferation and inflammatory cell infiltration in the interstitium, and protein casts in the renal tubules were observed. Myocardial cells were obviously hypertrophy and disordered. At 12 w, renal tubules were obviously expanded, the epithelium was flat, the brush border disappeared, and the interstitial fibrous connective tissue of the myocardial tissue was proliferated. The detection of TLR4 and MyD88 in kidney tissue and myocardial tissue revealed that the positive expression of TLR4 and MyD88 gradually increased over time. Therefore, the final result of the study is that uremia can gradually lead to myocardial hypertrophy and TLR4 and MyD88 are highly expressed in serum, kidney, and myocardial tissues of uremic rats, suggesting that TLR4 and MyD88 may be related to the degree of uremic disease and the myocardium caused by it. Hypertrophy is related.

Dietary Naringenin Preserves Insulin Sensitivity and Grip Strength and Attenuates Inflammation but Accelerates Weight Loss in a Mouse Model of Cancer Cachexia.

Cancer cachexia is characterized by the loss of skeletal muscle resulting in functional impairment, reduced quality of life and mortality. Naringenin, a flavonoid found in citrus fruits, improves insulin sensitivity and reduces inflammation and tumor growth in preclinical models. Therefore, the study hypothesizes that dietary supplementation of naringenin will improve insulin sensitivity, decrease inflammation, slow body weight loss, and delay tumor growth in a mouse model of cancer cachexia. Mice are fed 2 wt% dietary naringenin before and during initiation of cancer cachexia using inoculated adenocarcinoma-26 cells (C-26). Food intake, body weight, body composition, muscle function, insulin tolerance, and inflammatory status are assessed. Although naringenin-fed tumor-bearing mice exhibit reductions in body weight and food intake earlier than control diet-fed tumor-bearing mice, dietary naringenin is protective against loss of muscle strength, and attenuates the onset of insulin resistance and markers of inflammation. Dietary supplementation of naringenin improves multiple aspects of metabolic disturbance and inflammation during cancer cachexia progression in [C-26 tumor-bearing] mice. However, the acceleration of anorexia and weight loss is also observed. These findings emphasize the link between inflammation and insulin resistance as a basis for understanding their roles in the pathogenesis of cancer cachexia.

A CASE REPORT REGARDING MANAGEMENT OF GRAHANI DOSHA THROUGH AYURVEDA

Grahani as an organ is considered as the seat of Agni which is supported and nourished by Agni with Aadhara Aadheya Sambandha. This Agni is vitiated by Ama formed because of improper diet and regimen. Among them, Grahani dosha is the prime disease and is seen often in day-to-day practice. Material And Method: A 32-years- old male patient was coming to the OPD of Kaya Chiktsa,Quadra Institute of Ayurveda with complaints of defecation just after taking a meal, Bowelfrequency 4-5 times/day, irregular bowel habit, loss of appetite, gen- eralized weakness, occasional pain in the abdomen, slow weight gain. These complaints were persisting for the past1 year. This condition can be understood as Grahani Dosha, treatments including with somemedicine course of 2 months. Result: There were significant improvements in the condition of the patient. Discussion: while treat- ing Grahani, the drugs alleviating Vata, Pitta, Doshas, which are having Deepan, Pachana, Grahi, Stambhana as well possessing tikta, katu rasa and ushna veerya should be selected. there was a significant reduction in all the signs and symptoms ofthe disease are observed. Conclusion: A meticulous planning of treatment considering the Bala, and Agni of patient accompanied with proper diet will provide encouraging results in treating Grahani Dosha. Keywords: Grahani dosha, Agni, Aama, Stambhana.

Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain

Although antipsychotics, such as olanzapine, are effective in the management of psychiatric conditions, some patients experience excessive antipsychotic-induced weight gain (AIWG). To illuminate pathways underlying AIWG, we compared baseline blood gene expression profiles in two cohorts of mice that were either prone (AIWG-P) or resistant (AIWG-R) to weight gain in response to olanzapine treatment for two weeks. We found that transcripts elevated in AIWG-P mice relative to AIWG-R are enriched for high-confidence transcriptional targets of numerous inflammatory and immunomodulatory signaling nodes. Moreover, these nodes are themselves enriched for genes whose disruption in mice is associated with reduced body fat mass and slow postnatal weight gain. In addition, we identified gene expression profiles in common between our mouse AIWG-P gene set and an existing human AIWG-P gene set whose regulation by immunomodulatory transcription factors is highly conserved between species. Finally, we identified striking convergence between mouse AIWG-P transcriptional regulatory networks and those associated with body weight and body mass index in humans. We propose that immunomodulatory transcriptional networks drive AIWG, and that these networks have broader conserved roles in whole body-metabolism.

Problems of Nursing Care of Prematurely Born Children with Haemorrhagic Hydrocephalus — Case Report

Introduction. Hydrocephalus is a pathological condition leading to excessive accumulation of cerebrospinal fluidin the ventricular system of the brain. Hemorrhagic hydrocephalus is a result of an intracranial hemorrhage, whichis among the most common neurological complications in prematurely born newborns.Case Report. A male patient was born by caesarean section at 31 weeks, in severe condition. During ultrasonography,intraventricular hemorrhage III° was found. The patient was transported to a surgical clinic for the implantationof Rickham reservoir. The duty of the midwife was to solve a number of nursing problems, including: the risk ofincreased intracranial pressure, slow weight gain, infection or apnoea.Discussion. Intraventricular bleeding occurs mainly in children who are born prematurely. Prognosis in children afterintraventricular hemorrhage depends mainly on the severity of bleeding. In order to provide professional medicalcare, children with neurological complications should be treated in centres with the highest reference level, and thedecisive factor conditioning their proper psychomotor development in the future is early rehabilitation.Conclusions. Care for patients born prematurely with hemorrhagic hydrocephalus requires collaboration betweenthe medical staff and parents. The task of the midwife is to mitigate the negative effects of hydrocephalus as wellas support and educate parents. (JNNN 2021;10(1):42–47)

Body mass index trajectories during mid to late life and risks of mortality and cardiovascular outcomes: Results from four prospective cohorts.

BackgroundOur understanding of the weight-outcome association mainly comes from single-time body mass index (BMI) measurement. However, data on long-term trajectories of within-person changes in BMI on diverse study outcomes are sparse. Therefore, this study is to determine the associations of individual BMI trajectories and cardiovascular outcomes.MethodsThe present analysis was based on data from 4 large prospective cohorts and restricted to participants aged ≥45 years with at least two BMI measurements. Hazard ratios (HR) and 95% confidence intervals(95%CI) for each outcome according to different BMI trajectories were calculated in Cox regression models.FindingsThe final sample comprised 29,311 individuals (mean age 58.31 years, and 77.31% were white), with a median 4 BMI measurements used in this study. During a median follow-up of 21.16 years, there were a total of 10,192 major adverse cardiovascular events (MACE) and 11,589 deaths. A U-shaped relation was seen with all study outcomes. Compared with maintaining stable weight, the multivariate adjusted HR for MACE were 1.53 (95%CI 1.40–1.66), 1.26 (95%CI 1.16–1.37) and 1.08 (95%CI 1.02–1.15) respectively for rapid, moderate and slow weight loss; 1.01 (95%CI 0.95–1.07), 1.13 (95%CI 1.05–1.21) and 1.29 (95%CI 1.20–1.40) respectively for slow, moderate and rapid weight gain. Identical patterns of association were observed for all other outcomes. The development of BMI differed markedly between the outcome-free individuals and those who went on to experience adverse events, generally beginning to diverge 10 years before the occurrence of the events.InterpretationOur findings may signal an underlying high-risk population and inspire future studies on weight management.FundingNational Natural Science Foundation of China, Guangdong Natural Science Foundation.

Clinical follow-up and genetic analysis of six cases with hypophosphatasia

Objective: To analyze the clinical, genetic characteristics and follow-up data of Chinese patients with hypophosphatasia (HPP). Methods: A retrospective analysis was conducted on six children with HPP admitted to the Department of Endocrinology, Genetics and Metabolism in Beijing Children's Hospital from October 2010 to January 2019. Summarized the clinical and follow-up data of all six patients, as well as the pathogenic variants of five children. Results: The serum alkaline phosphatase levels of all six children (five males and one female) were significantly reduced (2-49 U/L). The 6 patients aged from 2 months to 6 years and 4 months, 4 infantile HPP, 1 childhood HIP and 1 odonto HPP. The four patients with infantile HPP presented with anorexia, slow weight gain and hypercalcemia, whereas the one patient with childhood HPP and the other patient with odonto HPP had tooth loss. The patient with childhood HPP also manifested with motor dysfunction. Genetic testing was conducted for five patients and 4 unrelated Chinese families and revealed 10 variations in ALPL gene, including 7 missense variation, 1 insertion variation, 1 frameshift variation, 1 deletion variation.Of which 3 were novel (p.Y28C, p.268, F>L, p.A176V).One of the infantile patients lost follow-up and the other three deceased. The clinical conditions were much improved with medical intervention for patients with childhood, orodonto HPP. Conclusions: While HPP patients with different ages of onset present with common features, the prognosis differ significantly. The prognosis is good for patients with childhood, orodonto HPP and poor for patients with infantile HPP. Genetic testing is the main method for definitive diagnosis.

A case of inversion of chromosome 4 and an unbalanced transloca- tion between the short arm of chromosome 4 and long arm of chromosome 18 in a girl: evolution of clinical and electroencephalographic manifestations

We report a case of a girl with a chromosomal disorder that has never been described in the literature: inversion of chromosome 4 with an unbalanced translocation between the short arm of chromosome 4 and long arm of chromosome 18. Clinical manifestations of this syndrome included severe growth retardation, very slow weight gain, optic nerve hypoplasia, pronounced delay in mental and motor development, and epilepsy with focal hemiclonic fever-related seizures of varying location. The patient has multiple stigmas of dysembryogenesis, but no abnormalities in the development of internal organs. The somatic status is complicated by chronic liquid aspiration and sleep apnea. Magnetic resonance imaging has demonstrated agenesis of the corpus callosum. In this article, we have summarized the results of clinical observation and electroencephalography findings obtained during several years. The type of epilepsy in this girl does not match Wolf–Hirschhorn syndrome (which is determined by her karyotype), but is similar to epilepsy in patients with aberrations of the long arm of chromosome 18.

A multi-layered SiC coating to protect graphite spheres from high temperature oxidation in static air

A multi-layered SiC coating was prepared on graphite spheres to improve its antioxidant performance. The oxidation behaviour of the coating prepared on graphite sphere in static air was studied systematically for the first time. As an antioxidant layer, the dense block layer is effective in protecting the internal transition layer and refined grain layer from oxidation in static air at 1773 K. An amorphous SiO2 layer developing on the surface acts as a protective shell, while some carbon particles developed at the interface of oxide layer and SiC coating. As for the oxidation process of the SiC coated graphite sphere, it is comprised of three stages. Stage I (0−6 h) is characterized by a rapid weight gain, which follows a linear model, and the passive oxidation of SiC occurs in this stage. Stage II (6−50 h) is characterized by a slow weight gain, which follows the parabolic oxidation model. Stage III (50−200 h) is characterized by an invariable weight gain of merely 0.52%, which is accompanied with the interface reaction of SiC and the self-healing of oxide layer.

A translationally controlled tumor protein (TCTP) is involved in growth and antagonistic behaviour of Trichoderma virens

Translationally controlled tumour proteins (TCTPs) are omnipresent in eukaryotes and play important physiological roles. This protein is identified as an allergen in the fungi Alternaria alternata and Cladosporium herbarum, and is involved in maintaining a balance between sexual and asexual differentiation in Aspergillus nidulans. MoTCTP regulates growth and conidiation in the plant pathogen Magnaporthe oryzae. We present here the functions of a TCTP orthologue (Tcp1) in the plant beneficial fungus Trichoderma virens. T. virens Tcp1 shares 42.94% and 39.88% sequence similarity with the evolutionarily distant human TCTP and maize TCTP, respectively. Based on prediction models, the secondary structure elements (α-helices and β-sheets) were found to be very well conserved barring a few insertions/deletions in the loop region. Using homologous recombination, we obtained three independent deletion mutants in this gene and a comparison of phenotypes with the wild type strain revealed that this protein has multiple functions in T. virens. Tcp1 knockout mutants showed slow radial growth and dry weight production. Δtcp1 mutants also lost the ability to overgrow the plant pathogenic fungi Sclerotium rolfsii and Rhizoctonia solani, but retained this property against the oomycete Pythium aphanidermatum reflecting selective loss of antagonistic ability. The mutants also lost the ability to colonize and kill the sclerotia of S. rolfsii.

EFFECTS OF NEEM OIL ON THE PRESERVATION OF MILICIA EXCELSA: EVALUATION OF TERMITICIDAL EFFECTIVENESS

Wood usage has increased with time, thus, there is need to investigate how wood can be treated with human and environmentally friendly preservative which is effective in protecting wood from termites and other agents of wood deterioration, or improve the wood physical, chemical, mechanical and biological characteristics. The aim of this study was therefore to evaluate the effects of neem oil on Milicia excelsa wood preservation. Treated and untreated pieces of Milicia excelsa wood samples were used to carry out this experiment, a soil bed, and an internal wood exposure to termite’s test was carried out, and measurements taken using a digital weighing machine. The results obtained showed that, when Milicia excelsa is treated with neem oil, its Rate of Decay (ROD) reduces as compared to the untreated pieces. Also, neem oil treated wood when exposed to termite’s attack experiences a slower weight loss compared to untreated samples with significant weight loss. Neem oil is thus not only effective in preserving woods, but also non- toxic to human and the environment.

Recent Perspectives on Social Frailty and Related Issue for the Elderly

Current situation has brought many people less physical and social activities across the world. Consequently, there has been some concern about the exacerbation of frailty, especially in the elderly. The problems for the elderly have oral frailty (OF), social frailty (SF) and physical frailty (PF). PF subdomains are slow gait speed, weakness, exhaustion, low activity and weight loss. Social frailty criteria have 7 factors including living alone, no education, absence of confidence, infrequent contact, infrequent social activities, financial difficulty, and socioeconomic deprivation. As useful index for social frailty, Social Frailty Index (SFI) and Tilburg Frailty Indicator (TFI) will be recommended.

Selection of carioca common bean lines with slow darkening

Abstract The objective of this work was to evaluate the interaction between genotypes and environment for seed-coat darkening of common bean (Phaseolus vulgaris) seeds, in order to select lines that combine slow darkening, upright plants, resistance to lodging, and higher yield and 100-grain weight, with good adaptability and stability for these traits. Forty four pre-selected lines, originating from crosses between one cultivar with slow darkening and prostrate plants and four cultivars with normal darkening and upright plants, were evaluated in field trials conducted in 15 environments (combinations of locations, crop seasons, and years). Considering the mean values, adaptability, and stability for each isolated trait, most of the lines presented satisfactory performance: 75% for slow darkening, 48% for high yield, 59% for upright plants, 84% for resistance to lodging, and 68% for 100-grain weight. The effects of environments and of the genotype by environment interaction are important for the five studied traits. The CNFC 16754 and CNFC 16820 lines present slow seed-coat darkening, high yield and 100-grain weight, more upright plant architecture, and greater resistance to lodging, besides high adaptability and stability for these traits, which shows their potential for recommendation as new cultivars and confirms that it is possible to join desirable phenotypes for the five traits evaluated.

Type 3 resistant starch from Canna edulis modulates obesity and obesity-related low-grade systemic inflammation in mice by regulating gut microbiota composition and metabolism.

Obesity is a most prevalent human health problem. Several studies showed that appropriate modulation of gut microbiota could help reshape the metabolic profile of obese individuals, thereby altering the development of obesity. A nutritional strategy for treating obesity includes prebiotics. Type 3 Resistant Starch from Canna edulis (Ce-RS3) is a dietary fiber that exerts potential effects on the intestinal microbial community; however, the metabolic landscape and anti-obesity mechanism remain unclear. In the present study, obese mice were treated with Ce-RS3, and 16S rRNA gene sequencing and metabolomics were used to measure changes in gut microbiota and fecal metabolic profiles, respectively. At the end of the treatment (13 weeks), we observed slow weight gain in the mice, and pathological damage and inflammation were substantially reduced. Ce-RS3 constructs a healthy gut microbiota structure and can enhance intestinal immunity and reduce metabolic inflammation. Ce-RS3 increased the diversity of gut microbiota with enrichment of Bifidobacterium and Roseburia. Ce-RS3 regulated the systemic metabolic dysbiosis in obese mice and adjusted 26 abnormal metabolites in amino acids and lipids metabolism, many of which are related to the microbiome. More importantly, we found that the anti-obesity effect of Ce-RS3 can be transferred by fecal transplantation. The beneficial effects of Ce-RS3 might derive from gut microbiota changes, which might improve obesity and metabolic inflammation by altering host-microbiota interactions with impacts on the metabolome. In conclusion, Ce-RS3 can be used as a prebiotic with potential value for the treatment of obesity.

Improved Detonation Performance Via Coordination Substitution: Synthesis and Characterization of Two New Green Energetic Coordination Polymers.

In this work, a new energetic coordination polymer (ECP), [Cu(HBTI)(H2O)]n (1) (H3BTI = 4,5-bistetrazole-imidazole), was synthesized by a hydrothermal method. Due to the existence of coordination water molecules in 1, however, its energy density was limited, which led to the insufficient detonation performance. To further improve its detonation performance, [Cu(H2BTI)(NO3)]n (2) was then obtained by substituting the coordinated water molecule in 1 with nitrate through the coordination substitution reaction under acidic conditions. The structures of two ECPs were respectively characterized using X-ray single-crystal diffraction, and the theoretical density of 2 (2.227 g·cm-3) was greater than 1 (1.851 g·cm-3). Thermogravimetric analyses showed that 2 has a one-step rapid weight loss process compared with the two-step slow weight loss process of 1. The theoretical calculations indicated that the detonation performances of 2 were better than those of 1. Moreover, the promotion effects of two ECPs on the combustion decomposition of ammonium perchlorate were studied using a differential scanning calorimetry method.

Short-term Outcomes of the Study of Refeeding to Optimize Inpatient Gains for Patients With Anorexia Nervosa

The standard of care for refeeding inpatients with anorexia nervosa, starting with low calories and advancing cautiously, is associated with slow weight gain and protracted hospital stay. Limited data suggest that higher-calorie refeeding improves these outcomes with no increased risk of refeeding syndrome. To compare the short-term efficacy, safety, and cost of lower-calorie vs higher-calorie refeeding for malnourished adolescents and young adults with anorexia nervosa. In this multicenter randomized clinical trial with prospective follow-up conducted at 2 inpatient eating disorder programs at large tertiary care hospitals, 120 adolescents and young adults aged 12 to 24 years hospitalized with anorexia nervosa or atypical anorexia nervosa and 60% or more of median body mass index were enrolled from February 8, 2016, to March 7, 2019. The primary analysis was a modified intent-to-treat approach. Higher-calorie refeeding, beginning at 2000 kcal/d and increasing by 200 kcal/d vs lower-calorie refeeding, beginning at 1400 k/cal and increasing by 200 kcal every other day. Main outcomes were end-of-treatment outcomes; the primary end point of this trial will be clinical remission over 12 months. Short-term efficacy was defined a priori as time to restore medical stability in the hospital, measured by the following 6 indices: 24-hour heart rate of 45 beats/min or more, systolic blood pressure of 90 mm Hg or more, temperature of 35.6 °C or more, orthostatic increase in heart rate of 35 beats/min or less, orthostatic decrease in systolic blood pressure of 20 mm Hg or less, and 75% or more of median body mass index for age and sex. The prespecified safety outcome was incidence of electrolyte abnormalities; cost efficacy was defined as savings associated with length of stay. Because 9 participants withdrew prior to treatment, the modified intention-to-treat analyses included 111 participants (93%; 101 females [91%]; mean [SD] age, 16.4 [2.5] years). Higher-calorie refeeding restored medical stability significantly earlier than lower-calorie refeeding (hazard ratio, 1.67 [95% CI, 1.10-2.53]; P = .01). Electrolyte abnormalities and other adverse events did not differ by group. Hospital stay was 4.0 days shorter (95% CI, -6.1 to -1.9 days) among the group receiving higher-calorie refeeding, which was associated with a savings of $19 056 (95% CI, -$28 819 to -$9293) in hospital charges per participant. In the first randomized clinical trial in the US to compare refeeding approaches in patients with anorexia nervosa and atypical anorexia nervosa, higher-calorie refeeding demonstrated short-term efficacy with no increase in safety events during hospitalization. ClinicalTrials.gov Identifier: NCT02488109.